Susan Avery, MD
Adult Medicine · Great Falls, MTNPI 1437244845
Payments from drug & device makers
Across 91 payments — averaging $23.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$444
- AbbVie$197
- Merck$196
- Exact Sciences$174
- Lilly USA, LLC$162
- Pfizer$144
- plus $789 from 14 others
What the payments were for
- Food & beverage$2,04297%
- Education$653%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $444 |
| AbbVie(2 entities) | 11 | $197 |
| Merck | 11 | $196 |
| Exact Sciences | 6 | $174 |
| Lilly USA, LLC | 7 | $162 |
| Pfizer | 7 | $144 |
| GSK | 6 | $118 |
| AstraZeneca(2 entities) | 6 | $113 |
| Astellas Pharma US Inc | 3 | $95 |
| Amgen | 4 | $81 |
| Boehringer Ingelheim | 3 | $73 |
| Kyowa Kirin, Inc. | 2 | $48 |
| Ascendis Pharma Endocrinology Inc | 2 | $45 |
| Novartis | 2 | $41 |
| Baxter Healthcare | 1 | $33 |
| Ultragenyx Pharmaceutical Inc. | 2 | $31 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Tandem Diabetes Care, Inc. | 1 | $30 |
| Radius Health, Inc. | 1 | $25 |
| Dexcom, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few adult medicine providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 70 | $69,621 |
| OzempicSemaglutide | 36 | $51,931 |
| FarxigaDapagliflozin Propanediol | 29 | $41,901 |
| Invega SustennaPaliperidone Palmitate | 12 | $39,121 |
| MounjaroTirzepatide | 24 | $38,490 |
| JanuviaSitagliptin Phosphate | 25 | $30,818 |
| JardianceEmpagliflozin | 22 | $30,185 |
| Tresiba Flextouch U-100Insulin Degludec | 25 | $17,257 |
| XareltoRivaroxaban | 18 | $17,107 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $14,415 |
| Breo ElliptaFluticasone/Vilanterol | 22 | $8,707 |
| Spiriva HandihalerTiotropium Bromide | 12 | $6,882 |
| Levothyroxine Sodium | 454 | $4,170 |
| Estradiol | 42 | $4,061 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $3,150 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $144 | $72,47984 claims |
| Novo NordiskOzempic | $444 | $51,93136 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $73 | $44,59935 claims |
| AstraZenecaFarxiga | $113 | $41,90129 claims |
| Lilly USA, LLCMounjaro | $162 | $38,49024 claims |
| MerckJanuvia | $196 | $30,81825 claims |
| GSKBreo Ellipta | $118 | $8,70722 claims |
| AbbVieSynthroid, Armour Thyroid | $197 | $4,13353 claims |
| Sanofi-aventis U.S. LLCLantus | $31 | $1,13416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few adult medicine providers in Montanaon file to place this against a meaningful peer group, so we don't.
Other adult medicine in Great Falls
- Roger PaffordAnaconda$647
- Megan MackeHelena$179
- Jeffrey AdamsMissoula$57
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.